Robotic-assisted intracranial aneurysm treatment: 1 year follow-up imaging and clinical outcomes.
aneurysm
brain
coil
stent
technology
Journal
Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
31
05
2021
accepted:
06
10
2021
pubmed:
17
12
2021
medline:
18
11
2022
entrez:
16
12
2021
Statut:
ppublish
Résumé
The use of robotics in medicine may enable increased technical accuracy, reduced procedural time and radiation exposure, and remote completion of procedures. We have previously described the first-in-human, robotic-assisted cerebral aneurysm treatment using the CorPath GRX Robotic System. In this report we discuss our early experiences and outcomes using this robotic device for endovascular treatment of intracranial aneurysms using stent-assisted coil embolization and flow diversion. The patient and disease characteristics, procedural details, and follow-up imaging and clinical outcomes of consecutive patients undergoing robotically-assisted intracranial aneurysm embolization between November 2019 and February 2020 are presented. Six patients underwent robotically-assisted embolization of intracranial aneurysms. Four of the patients were treated with a neck-bridging stent (with or without coiling) and two patients were treated with a flow-diverting stent. Two patients were treated in the subacute period of subarachnoid hemorrhage and four patients were treated electively. All of the procedures could be completed robotically and there was no need for unplanned manual intervention. The technical success rate of the procedures was 100%. There was no morbidity or mortality associated with the procedures. One year follow-up imaging showed that four aneurysms were completely obliterated (Raymond-Roy Occlusion Classification (RROC) class I) and the remaining two were occluded with a residual neck (RROC class II). The Corpath GRX Robotic System demonstrated a precise control over the microcatheter, wire and stent during aneurysm treatment. Robotic neuro-procedures seem to be safe and effective and demonstrate stable occlusion results in the midterm follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
The use of robotics in medicine may enable increased technical accuracy, reduced procedural time and radiation exposure, and remote completion of procedures. We have previously described the first-in-human, robotic-assisted cerebral aneurysm treatment using the CorPath GRX Robotic System. In this report we discuss our early experiences and outcomes using this robotic device for endovascular treatment of intracranial aneurysms using stent-assisted coil embolization and flow diversion.
METHODS
METHODS
The patient and disease characteristics, procedural details, and follow-up imaging and clinical outcomes of consecutive patients undergoing robotically-assisted intracranial aneurysm embolization between November 2019 and February 2020 are presented.
RESULTS
RESULTS
Six patients underwent robotically-assisted embolization of intracranial aneurysms. Four of the patients were treated with a neck-bridging stent (with or without coiling) and two patients were treated with a flow-diverting stent. Two patients were treated in the subacute period of subarachnoid hemorrhage and four patients were treated electively. All of the procedures could be completed robotically and there was no need for unplanned manual intervention. The technical success rate of the procedures was 100%. There was no morbidity or mortality associated with the procedures. One year follow-up imaging showed that four aneurysms were completely obliterated (Raymond-Roy Occlusion Classification (RROC) class I) and the remaining two were occluded with a residual neck (RROC class II).
CONCLUSIONS
CONCLUSIONS
The Corpath GRX Robotic System demonstrated a precise control over the microcatheter, wire and stent during aneurysm treatment. Robotic neuro-procedures seem to be safe and effective and demonstrate stable occlusion results in the midterm follow-up.
Identifiants
pubmed: 34911735
pii: neurintsurg-2021-017865
doi: 10.1136/neurintsurg-2021-017865
pmc: PMC9685724
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1229-1233Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: VMP is an unpaid member of the neuro-advisory board of Corindus. KD, JMS and RT work at Corindus (robotic company).
Références
IEEE Trans Biomed Eng. 1988 Feb;35(2):153-60
pubmed: 3280462
Neurosurg Focus. 2017 May;42(5):E9
pubmed: 28463622
J Neurosurg. 2019 Nov 29;:1-7
pubmed: 31783367
Clin Neuroradiol. 2020 Jun;30(2):203-208
pubmed: 32607626
Catheter Cardiovasc Interv. 2004 Dec;63(4):407-11
pubmed: 15558765
J Neurointerv Surg. 2020 Apr;12(4):338-340
pubmed: 32132138
Expert Rev Med Devices. 2020 Sep;17(9):919-927
pubmed: 32835546
Interv Neuroradiol. 2012 Sep;18(3):275-83
pubmed: 22958765
Neurosurg Focus. 2017 May;42(5):E7
pubmed: 28463617
J Am Coll Cardiol. 2013 Apr 16;61(15):1596-600
pubmed: 23500318
J Neurointerv Surg. 2015 Jul;7(7):496-502
pubmed: 24898735
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E327-E332
pubmed: 32583944
Int J Cardiol. 2013 Sep 1;167(5):1843-7
pubmed: 22608271
Spine (Phila Pa 1976). 2018 Dec 1;43(23):1670-1677
pubmed: 29672420
J Neurointerv Surg. 2021 Mar;13(3):272-277
pubmed: 32601259
J Invasive Cardiol. 2016 Nov;28(11):E128-E131
pubmed: 27801660
EClinicalMedicine. 2019 Sep 03;14:53-58
pubmed: 31709402